Axsome Therapeutics (AXSM) Share-based Compensation (QoQ) (2015 - 2026)
Axsome Therapeutics (AXSM) Share-based Compensation (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,981.90 Bn | 66,981.62 Bn | - |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - |
| 4 | BeOne Medicines | 472.11 Bn | 467.32 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.89 Bn | 114.65 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.93 Bn | 61.18 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - |
| 8 | Argenx Se | 55.82 Bn | 50.63 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.49 Bn | 37.49 Bn | - |
| 10 | Axsome Therapeutics | 12.32 Bn | 12.02 Bn | 176.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 283.60% |
| Dec 31, 2025 | -73.55% |
| Sep 30, 2025 | -82.73% |
| Jun 30, 2025 | 474.05% |
| Mar 31, 2025 | -71.51% |
| Dec 31, 2024 | 277.65% |
| Sep 30, 2024 | 1.30% |
| Jun 30, 2024 | 7,027.33% |
| Mar 31, 2024 | -95.20% |
| Dec 31, 2023 | -61.83% |
| Sep 30, 2023 | 2.80% |
| Jun 30, 2023 | 1,736.45% |
| Mar 31, 2023 | -97.68% |
| Dec 31, 2022 | 406,086.80% |
| Sep 30, 2022 | -9.50% |
| Jun 30, 2022 | -99.87% |
| Mar 31, 2022 | 28.99% |
| Dec 31, 2021 | 2.89% |
| Sep 30, 2021 | 4.93% |
| Jun 30, 2021 | 46.24% |